Results 31 to 40 of about 19,175 (268)
Clinical Case Reports, 2021 The identification of Candida auris fungemia in critically ill COVID‐19 patients is detrimental, with huge implications on patient mortality and infectious control measures.
Wael Goravey +5 more
semanticscholar +1 more source
Journal of Microbiology, Immunology and Infection, 2018 Backgrounds: Candida guilliermondii is rarely isolated from clinical specimen. C. guilliermondii fungemia is seldom reported in the literature. The aims of this study were to report the clinical features, antifungal susceptibility, and outcomes of ...
Ting-Yu Tseng +8 more
doaj +1 more source
Saccharomyces cerevisiae fungemia due to an unexpected source in the pediatric intensive care unit
The Turkish Journal of Pediatrics, 2022 Background. Saccharomyces cerevisiae is one of the microorganisms commonly used as a probiotic. Although it is primarily known as non-pathogenic, it may cause fungemia, particularly in immunocompromised patients or children with a history of long ...
Emrah Gün +4 more
doaj +1 more source
Journal of Infection in Developing Countries, 2021 Introduction: Fungemia in preterm infants results in high mortality and morbidity. The genotypes, drug susceptibilities of Candida pelliculosa strains, and clinical features of two outbreaks of neonatal candidemia caused by C. pelliculosa were analyzed,
Yulan Yang +5 more
doaj +1 more source
Adult liver transplantation: An analysis of the early causes of death in 40 consecutive cases [PDF]
, 1986 One hundred twenty‐nine adult patients who received an orthotopic liver transplantation and survived at least 24 hr after surgery were evaluated. During the period of follow‐up, 48 of the 129 patients (37%) died.
Calne +17 more
core +1 more source
Prevalence and factors predictive of intraocular fungal infection in patients with fungemia at an academic urban tertiary care center [PDF]
, 2015 Objective To report the prevalence and to identify factors predictive of intraocular infection in patients with fungemia receiving prophylactic antifungal therapy.
Braich, Puneet S +4 more
core +4 more sources
Clinical Case Reports, 2021 Rhodotorula mucilaginosa is an emerging fungal infection with the ability of biofilms formation. The identification of R mucilaginosa fungemia should trigger reflexes of prompt central venous line removal and using Amphotericin therapy.
Wael Goravey +5 more
semanticscholar +1 more source
Journal of Microbiology, Immunology and Infection, 2018 Background: Candida pelliculosa is a rare pathogen of fungemia. There have been a few nosocomial outbreaks of C. pelliculosa fungemia in nurseries and pediatric intensive care units (ICU), hematologic units, and surgical ICU. We describe an epidemiologic
Jiwon Jung +5 more
doaj +1 more source
Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
Medical Mycology Case Reports, 2017 Probiotics are commonly prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by Clostridium difficile. We report the case of an immunocompromised 73-year-old patient on chemotherapy who developed Saccharomyces cerevisiae ...
Marcelo C. Appel-da-Silva +4 more
doaj +1 more source
Unusual fungemia in a patient with metastatic gastric cancer
Journal of Cancer Research and Practice, 2018 Kodamaea ohmeri, a yeast used in food industry, is an emerging opportunist causing sepsis, endocarditis, cellulitis, urinary tract infection, peritonitis. Only 40 cases of Kodamaea ohmeri fungemia were reported worldwide till 2017.
Jeffrey Peng Huang +2 more
doaj +1 more source